Omnicell Profit Margin 2011-2025 | OMCL

Current and historical gross margin, operating margin and net profit margin for Omnicell (OMCL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Omnicell net profit margin as of September 30, 2025 is 1.69%.
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.596B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.812B 58.34
Tempus AI (TEM) United States $11.803B 0.00
Doximity (DOCS) United States $9.361B 38.54
Hims & Hers Health (HIMS) United States $8.207B 66.76
IRhythm Technologies (IRTC) United States $5.429B 0.00
Hinge Health (HNGE) United States $3.287B 0.00
Privia Health (PRVA) United States $2.921B 182.69
Heartflow (HTFL) United States $2.635B 0.00
Inspire Medical Systems (INSP) United States $2.522B 41.72
10x Genomics (TXG) United States $2.035B 0.00
Enovis (ENOV) United States $1.765B 9.27
Azenta (AZTA) United States $1.370B 59.76
Phreesia (PHR) United States $1.350B 0.00
Clover Health Investments (CLOV) United States $1.276B 0.00
Schrodinger (SDGR) United States $1.267B 0.00
Fulgent Genetics (FLGT) United States $0.915B 0.00
Claritev (CTEV) United States $0.730B 0.00
Talkspace (TALK) United States $0.535B 107.67
Veradigm (MDRX) United States $0.534B 0.00
Butterfly Network (BFLY) United States $0.523B 0.00
Evolent Health (EVH) United States $0.464B 0.00
Standard BioTools (LAB) United States $0.461B 0.00
Zepp Health (ZEPP) Netherlands $0.365B 0.00
Carlsmed (CARL) United States $0.338B 0.00
TruBridge (TBRG) United States $0.306B 14.08
SOPHiA GENETICS SA (SOPH) Switzerland $0.296B 0.00
CapsoVision (CV) United States $0.265B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.225B 0.00
KORU Medical Systems (KRMD) United States $0.202B 0.00
MDxHealth SA (MDXH) Belgium $0.188B 0.00
Nyxoah SA (NYXH) Belgium $0.181B 0.00
Health Catalyst (HCAT) United States $0.166B 0.00
CareCloud (CCLD) United States $0.135B 7.40
EUDA Health Holdings (EUDA) Singapore $0.113B 0.00
Outset Medical (OM) United States $0.089B 0.00
NetraMark Holdings (AINMF) Canada $0.076B 0.00
Pulmonx (LUNG) United States $0.066B 0.00
American Well (AMWL) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
Evaxion - (EVAX) Denmark $0.036B 0.00
111 (YI) China $0.035B 0.00
Precipio (PRPO) United States $0.032B 0.00
Predictive Oncology (POAI) United States $0.027B 0.00
Lunai Bioworks (LNAI) United States $0.024B 0.00
Zhongchao (ZCMD) China $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
Bullfrog AI Holdings (BFRG) United States $0.010B 0.00
Movano (MOVE) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00